- 专利标题: Formulations containing sphinganine
-
申请号: US14908195申请日: 2014-07-01
-
公开(公告)号: US09913789B2公开(公告)日: 2018-03-13
- 发明人: Tim Köhler , Mike Farwick , Matthias Mentel , Peter Lersch
- 申请人: Evonik Degussa GmbH
- 申请人地址: DE Essen
- 专利权人: Evonik Degussa GmbH
- 当前专利权人: Evonik Degussa GmbH
- 当前专利权人地址: DE Essen
- 代理机构: Law Office of: Michael A. Sanzo, LLC
- 优先权: DE102013214713 20130729
- 国际申请: PCT/EP2014/063917 WO 20140701
- 国际公布: WO2015/014558 WO 20150205
- 主分类号: A61K8/41
- IPC分类号: A61K8/41 ; A61K31/133 ; A61K31/191 ; A61K31/198 ; A61K31/201 ; A61K31/205 ; A61K31/4168 ; A61K31/4188 ; A61K31/506 ; A61K31/522 ; A61K8/36 ; A61K8/44 ; A61K8/49 ; A61K8/63 ; A61Q5/12 ; A61Q7/00 ; A61K8/67
摘要:
The present invention relates to formulations comprising A) sphinganine and B) at least one active ingredient selected from the group creatine, creatinine, caffeine, carnitine, biotin, arjunolic acid, xymenynic acid, minoxidil, arginine and derivatives thereof.
公开/授权文献
- US20160184204A1 FORMULATIONS CONTAINING SPHINGANINE 公开/授权日:2016-06-30
信息查询